This study was performed to assess the neuroprotective effects of methanolic extracts from sweet persimmon peel (PPE) against glutamate-induced cytotoxicity in hybridoma N18-RE-105 cells. The neuroprotective effects of PPE in N18-RE-105 cells were measured using the MTT reduction assay, LDH release assay, and phase-contrast microscopy. The results of the MTT reduction assay showed that treating cells with 500 μg/mL PPE resulted in cell viability of 66.9%. Additionally, the morphological changes and the results of the LDH release assay showed that glutamate-induced damage to nerve cells was strongly inhibited by PPE. GSH content of N18-RE-105 cells was 3.5 μM compared to that of the control, whereas pretreatment with 500 μg/mL PPE increased GSH content by 4.7 μM. PPE was fractionated with hexane, and that layer had the highest neuroprotective effects in glutamate-stressed N18-RE-105 cells. In conclusion, our data showed that glutamate potentiated the effects of N18-RE-105 cell death by a mechanism involving oxidative stress. Therefore, PPE may be a potential candidate for prevention and therapy of neurodegenerative diseases.
The cell viability was measured using a morphological analysis. The cells were exposed to PPE and morphological changes were monitored for 24 hr (a: control, b: 20 mM glutamate, c: 20 mM glutamate/100 μg/mL PPE, d: 20 mM glutamate/500 μg/mL PPE). Photographs were taken with a phase contrast microscope at 100 ×magnification Treatment GSH levels (uM) Control 7.3 ± 0.71 Glutamate 3.4 ± 0.13 PPE (100 μg/mL) + glutamate 3.7 ± 0.14 PPE (500 μg/mL) + glutamate 4.6 ± 0.73*
The cells were seeded and grown for 24 hr, and then they were treated with 20 mM glutamate. After 24 hr, cells were removed and analyzed for GSH levels. *significantly different from glutamate-treated control group (p<0.05) 
